Get the latest tech news

Drugmaker to testify on why weight-loss drugs cost 15x more in the US


Bernie Sanders cancels subpoena vote.

On second thought — Enlarge/ Lars Fruergaard Jorgensen, chief executive officer Novo Nordisk A/S, during an interview at the company's headquarters in Bagsvaerd, Denmark, on Monday, June 12, 2023. "Novo Nordisk currently charges Americans with type 2 diabetes $969 a month for Ozempic, while this same exact drug can be purchased for just $155 in Canada and just $59 in Germany," Sanders wrote in April. In May, Novo Nordisk responded with a letter to Sanders, arguing that blame for high prices in the US lies with the country's complex health system and with middle managers who take cuts, according to Bloomberg.

Get the Android app

Or read this on Hacker News

Read more on:

Photo of loss drugs

loss drugs

Photo of Drugmaker

Drugmaker

Photo of 15x

15x

Related news:

News photo

"Outrageously" priced weight-loss drugs could bankrupt US health care

News photo

Oprah Hypes Zepbound and Wegovy, But Keeps Her Choice Secret

News photo

Novartis CEO on Acquisitions, AI, Weight-Loss Drugs